Current State of the Art in the Adjuvant Systemic Treatment of Premenopausal Patients With Early Breast Cancer

被引：5

作者：

Parisi, Francesca ^{[1
,2
]}

Razeti, Maria Grazia ^{[1
,2
]}

Blondeaux, Eva ^{[2
,3
]}

Arecco, Luca ^{[1
,2
]}

Perachino, Marta ^{[1
,2
]}

Tagliamento, Marco ^{[2
,3
]}

Levaggi, Alessia ^{[1
]}

Fregatti, Piero ^{[4
,5
]}

Poggio, Francesca ^{[3
]}

Lambertini, Matteo ^{[1
,2
]}

机构：

[1] IRCCS Osped Policlin San Martino, Dept Med Oncol, UOC Clin Oncol Med, Genoa, Italy

[2] Univ Genoa, Sch Med, Dept Internal Med & Med Specialties DiMI, Genoa, Italy

[3] IRCCS Osped Policlin San Martino, Dept Med Oncol, UO Oncol Med 2, Genoa, Italy

[4] IRCCS Osped Policlin San Martino, UOC Clin Chirurg Senol, Genoa, Italy

[5] Univ Genoa, Sch Med, Dept Integrated Diagnost Surg Sci, Genoa, Italy

来源：

CLINICAL MEDICINE INSIGHTS-ONCOLOGY | 2020年 / 14卷

关键词：

Breast cancer; premenopausal; adjuvant; BRCA; survivorship; OVARIAN-FUNCTION SUPPRESSION; INTERNATIONAL CONSENSUS GUIDELINES; DOCETAXEL PLUS CYCLOPHOSPHAMIDE; CHEMOTHERAPY-INDUCED AMENORRHEA; DOSE-DENSE CHEMOTHERAPY; YOUNG-WOMEN; ENDOCRINE THERAPY; REPORTED OUTCOMES; PHASE-III; DOUBLE-BLIND;

D O I：

10.1177/1179554920931816

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Breast cancer is the most frequent malignancy diagnosed in premenopausal women. In this age group, breast tumors tend to be diagnosed at more advanced stages and to harbor more aggressive biological features. In addition, specific age-related issues including genetic counseling, fertility preservation, impact on social and couple relationships, working life. and management of long-term side effects should be considered highly relevant when managing early breast cancer in premenopausal women. Therefore, the care of these patients is particularly complex and a multidisciplinary approach is mandatory. The present review summarizes the current state of art in the adjuvant systemic treatment of premenopausal women with early breast cancer focusing on the optimal chemotherapy. endocrine therapy, and targeted therapy approaches in this specific patient population.

引用

页数：10

共 91 条

[1] The Effects of Paclitaxel, Dose Density, and Trastuzumab on Treatment-Related Amenorrhea in Premenopausal Women With Breast Cancer
Abusief, Mary E.
Missmer, Stacey A.
Ginsburg, Elizabeth S.
Weeks, Jane C.
Partridge, Ann H.
[J]. CANCER, 2010, 116 (04) : 791 - 798
[2] Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials
Albain, K.
Anderson, S.
Arriagada, R.
Barlow, W.
Bergh, J.
Bliss, J.
Buyse, M.
Cameron, D.
Carrasco, E.
Clarke, M.
Correa, C.
Coates, A.
Collins, R.
Costantino, J.
Cutter, D.
Cuzick, J.
Darby, S.
Davidson, N.
Davies, C.
Davies, K.
Delmestri, A.
Di Leo, A.
Dowsett, M.
Elphinstone, P.
Evans, V.
Ewertz, M.
Gelber, R.
Gettins, L.
Geyer, C.
Goldhirsch, A.
Godwin, J.
Gray, R.
Gregory, C.
Hayes, D.
Hill, C.
Ingle, J.
Jakesz, R.
James, S.
Kaufmann, M.
Kerr, A.
MacKinnon, E.
McGale, P.
McHugh, T.
Norton, L.
Ohashi, Y.
Paik, S.
Pan, H. C.
Perez, E.
Peto, R.
Piccart, M.
[J]. LANCET, 2012, 379 (9814) : 432 - 444
[3] Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials
Alberro, J. A.
Ballester, B.
Deulofeu, P.
Fabregas, R.
Fraile, M.
Gubern, J. M.
Janer, J.
Moral, A.
de Pablo, J. L.
Penalva, G.
Puig, P.
Ramos, M.
Rojo, R.
Santesteban, P.
Serra, C.
Sola, M.
Solarnau, L.
Solsona, J.
Veloso, E.
Vidal, S.
Abe, O.
Abe, R.
Enomoto, K.
Kikuchi, K.
Koyama, H.
Masuda, H.
Nomura, Y.
Ohashi, Y.
Sakai, K.
Sugimachi, K.
Toi, M.
Tominaga, T.
Uchino, J.
Yoshida, M.
Coles, C. E.
Haybittle, J. L.
Moebus, V.
Leonard, C. F.
Calais, G.
Garaud, P.
Collett, V.
Davies, C.
Delmestri, A.
Sayer, J.
Harvey, V. J.
Holdaway, I. M.
Kay, R. G.
Mason, B. H.
Forbe, J. F.
Franci, P. A.
[J]. LANCET ONCOLOGY, 2018, 19 (01) : 27 - 39
[4] von Minckwitz Gunter, 2017, N Engl J Med, V377, P122, DOI [10.1056/NEJMx170011, 10.1056/NEJMoa1703643]
[5] Biology of breast cancer in young women
Azim, Hatem A., Jr.
Partridge, Ann H.
[J]. BREAST CANCER RESEARCH, 2014, 16 (04):
[6] Twelve-Month Estrogen Levels in Premenopausal Women With Hormone Receptor-Positive Breast Cancer Receiving Adjuvant Triptorelin Plus Exemestane or Tamoxifen in the Suppression of Ovarian Function Trial (SOFT): The SOFT-EST Substudy
Bellet, Meritxell
Gray, Kathryn P.
Francis, Prudence A.
Lang, Istvan
Ciruelos, Eva
Lluch, Ana
Angel Climent, Miguel
Catalan, Gustavo
Avella, Antoni
Bohn, Uriel
Gonzalez-Martin, Antonio
Ferrer, Roser
Catalan, Roberto
Azaro, Analia
Rajasekaran, Agnita
Morales, Josefa
Vazquez, Josep
Fleming, Gini F.
Price, Karen N.
Regan, Meredith M.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (14) : 1584 - U89
[7] Patient-reported outcomes with adjuvant exemestane versus tamoxifen in premenopausal women with early breast cancer undergoing ovarian suppression (TEXT and SOFT): a combined analysis of two phase 3 randomised trials
Bernhard, Juerg
Luo, Weixiu
Ribi, Karin
Colleoni, Marco
Burstein, Harold J.
Tondini, Carlo
Pinotti, Graziella
Spazzapan, Simon
Ruhstaller, Thomas
Puglisi, Fabio
Pavesi, Lorenzo
Parmar, Vani
Regan, Meredith M.
Pagani, Olivia
Fleming, Gini F.
Francis, Prudence A.
Price, Karen N.
Coates, Alan S.
Gelber, Richard D.
Goldhirsch, Aron
Walley, Barbara A.
[J]. LANCET ONCOLOGY, 2015, 16 (07) : 848 - 858
[8] Dose-dense adjuvant chemotherapy in early breast cancer patients: 15-year results of the Phase 3 Mammella InterGruppo (MIG)-1 study
Blondeaux, Eva
Lambertini, Matteo
Michelotti, Andrea
Conte, Benedetta
Benasso, Marco
Dellepiane, Chiara
Bighin, Claudia
Pastorino, Simona
Levaggi, Alessia
D' Alonzo, Alessia
Poggio, Francesca
Buzzatti, Giulia
Molinelli, Chiara
Fregatti, Piero
Bertoglio, Sergio
Boccardo, Francesco
Del Mastro, Lucia
[J]. BRITISH JOURNAL OF CANCER, 2020, 122 (11) : 1611 - 1617
[9] Anthracyclines in Early Breast Cancer: The ABC Trials-USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 (NRG Oncology)
Blum, Joanne L.
Flynn, Patrick J.
Yothers, Greg
Asmar, Lina
Geyer, Charles E., Jr.
Jacobs, Samuel A.
Robert, Nicholas J.
Hopkins, Judith O.
O'Shaughnessy, Joyce A.
Dang, Chau T.
Gomez, Henry Leonidas
Fehrenbacher, Louis
Vukelja, Svetislava J.
Lyss, Alan P.
Paul, Devchand
Brufsky, Adam M.
Jeong, Jong-Hyeon
Colangelo, Linda H.
Swain, Sandra M.
Mamounas, Eleftherios P.
Jones, Stephen E.
Wolmark, Norman
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (23) : 2647 - +
[10] Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37298 women with early breast cancer in 26 randomised trials
Boddington, C.
Bradley, R.
Braybrooke, J.
Burrett, J.
Clarke, M.
Davies, C.
Davies, L.
Dodwell, D.
Duane, F.
Evans, V.
Gettins, L.
Godwin, J.
Gray, R.
Hills, R.
James, S.
Liu, H.
Liu, Z.
MacKinnon, E.
Mannu, G.
McGale, P.
McHugh, T.
Morris, P.
Pan, H.
Peto, R.
Read, S.
Taylor, C.
Wang, Y.
Wang, Z.
Bradley, R.
Braybrooke, J.
Gray, R.
Bergh, J.
Peto, R.
Gray, Richard
Bradley, Rosie
Braybrooke, Jeremy
Liu, Zulian
Peto, Richard
Davies, Lucy
Dodwell, David
McGale, Paul
Pan, Hongchao
Taylor, Carolyn
Barlow, William
Bliss, Judith
Bruzzi, Paolo
Cameron, David
Fountzilas, George
Loibl, Sibylle
Mackey, John
[J]. LANCET, 2019, 393 (10179) : 1440 - 1452

← 1 2 3 4 5 6 7 8 9 10 →